Date Title Description PDF
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download
21 Feb 2023 On business and financial situation The company releases the Integrated Report for the year 2022 Download
21 Feb 2023 About Corporate Governance The Company informs about the agreements adopted by the Board of Directors Download

Pages

Date Title Description PDF
24 Feb 2021 On business and financial situation The company releases the press release related to 2020 financial results Download
24 Feb 2021 On business and financial situation ROVI releases the 2020 Results presentation Download
24 Feb 2021 Annual Corporate Governance Report ROVI releases the 2020 Annual Corporate Governance Report Download
24 Feb 2021 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2020 annual report regarding remuneration of the members of the Board of Directors  Download
11 Jan 2021 Liquidity contracts and specialists Liquidity contract: transactions conducted in the fourth quarter of 2020 Download

Pages

Date Title Description PDF
28 Jul 2016 Información sobre resultados (2) ROVI releases the press release related to the 2016 first half results Download
28 Jul 2016 Información sobre resultados ROVI releases the presentation related to the 2016 first half results Download
05 Jul 2016 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the second quarter of 2016 Download
24 Jun 2016 Información sobre dividendos The Company informs about the dividends payment Download
31 May 2016 Convocatorias y acuerdos de Juntas y Asambleas generales ROVI releases the information related to the agreements adopted by the 2016 General Shareholders Meeting Download

Pages